+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Toxicology Drug Screening Market by Test Type, Product Type, Sample Type, Drug Class, Application, End User - Global Forecast 2025-2030- Product Image
Toxicology Drug Screening Market by Test Type, Product Type, Sample Type, Drug Class, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Toxicology Drug Screening Market by Test Type, Product Type, Sample Type, Drug Class, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5675244
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global toxicology drug screening market is experiencing significant transformation, driven by advanced analytical techniques, stricter regulatory expectations, and a growing need for reliable and efficient screening across diverse sectors. Senior leaders seeking actionable market intelligence will find in-depth insights throughout this structured summary and analysis.

Market Snapshot: Toxicology Drug Screening Market Growth and Outlook

The Toxicology Drug Screening Market grew from USD 30.59 billion in 2024 to USD 34.82 billion in 2025. It is expected to continue growing at a CAGR of 13.47%, reaching USD 65.31 billion by 2030.

Scope & Segmentation of the Toxicology Drug Screening Market

This report evaluates the market’s landscape across technology, end use, application, and regional variables to deliver granular, actionable insights for executive teams. Segment coverage is outlined as follows:

  • Test Types: Chromatography and Mass Spectrometry (Gas Chromatography-Mass Spectrometry, Liquid Chromatography-Tandem Mass Spectrometry), Immunoassay, Molecular Diagnostics (Next-Generation Sequencing, PCR-Based Testing), Rapid Testing
  • Product Types: Chromatography Systems, Confirmation Services, Consultation Services, Enzyme-Linked Immunosorbent Assay Kits, Lateral Flow Immunoassay Kits, Mass Spectrometers, PCR Instruments, Screening Services
  • Sample Types: Blood (Plasma, Whole Blood), Hair, Oral Fluid, Saliva, Urine
  • Drug Classes: Amphetamines, Benzodiazepines, Cannabis, Cocaine, Opiates
  • Applications: Clinical Diagnostics, Forensic Testing, Pain Management, Sports Anti-Doping, Workplace Testing
  • End Users: Government and Military Laboratories, Home Care Testing, Hospitals and Clinics, Independent Laboratories, Research Institutes
  • Geographic Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g., United Kingdom, Germany, United Arab Emirates, Nigeria, Turkey), Asia-Pacific (e.g., China, India, Japan, Australia, Singapore)
  • Companies Profiled: Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Agilent Technologies, Inc., Shimadzu Corporation, PerkinElmer, Inc., Waters Corporation, Bio-Rad Laboratories, Inc., Randox Laboratories Ltd

Key Takeaways for Senior Decision-Makers

  • Cutting-edge molecular and chromatographic methods coexist with rapid, point-of-care tests, providing both depth and versatility in toxicology drug screening services.
  • Automation, laboratory information management integration, and partnerships with software providers continue to redefine process efficiency, accuracy, and data management across laboratory settings.
  • Expansion of rapid testing has enabled screening in non-traditional settings, such as home care and outreach clinics, meeting urgent needs in pain management and workplace safety.
  • Strategic alliances and collaborations between traditional instrument manufacturers and digital technology firms are reshaping product offerings and accelerating adoption of AI-driven analytics.
  • Regional and regulatory variations, especially in North America, EMEA, and Asia-Pacific, require carefully tailored implementation strategies to maximize returns on investment and compliance.

Tariff Impact: Navigating Supply Chain and Cost Structure Volatility

Recent United States tariffs have impacted global toxicology drug screening supply chains, triggering shifts in sourcing strategies and supplier diversification. Many companies are renegotiating contracts, investing in redundancy, and stepping up in-house reagent production to build resilience and manage procurement risk. These dynamics are encouraging innovation in miniaturized reagents, instrument consolidation, and streamlined workflows, making operational efficiency a top priority.

Research Methodology & Data Sources

Research for this market report combined direct interviews with laboratory leaders, analytical technology manufacturers, and regulatory stakeholders, together with an extensive review of peer-reviewed literature and corporate filings. Quantitative and qualitative data points were triangulated across multiple sources for accuracy and reliability.

Why This Report Matters for Leadership Teams

  • Enables data-driven investment and technology adoption decisions aligned to real market trends and regulatory shifts.
  • Outlines optimal approaches for supply chain resilience, talent development, and operational efficiency for sustainable market leadership.

Conclusion

Senior executives committed to advancing toxicology drug screening will benefit from this report’s actionable intelligence, enabling effective strategy formulation amid a dynamic global landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of high-throughput mass spectrometry platforms for comprehensive multi-analyte drug screening
5.2. Emergence of artificial intelligence models to interpret complex drug metabolite patterns in toxicology tests
5.3. Shift towards non-invasive sampling methods such as oral fluid and breath analysis for drug detection
5.4. Growing demand for point-of-care toxicology screening devices in emergency departments for rapid decision making
5.5. Regulatory initiatives promoting harmonization of immunoassay screening protocols across global forensic laboratories
5.6. Adoption of novel microfluidic chip technologies to miniaturize and accelerate toxicological analysis workflows
5.7. Expansion of multiresidue LC-MS/MS panels enabling simultaneous detection of prescription, illicit, and novel psychoactive substances
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Toxicology Drug Screening Market, by Test Type
8.1. Introduction
8.2. Chromatography And Mass Spectrometry
8.2.1. Gas Chromatography-Mass Spectrometry
8.2.2. Liquid Chromatography-Tandem Mass Spectrometry
8.3. Immunoassay
8.4. Molecular Diagnostics
8.4.1. Next-Generation Sequencing
8.4.2. PCR-Based Testing
8.5. Rapid Testing
9. Toxicology Drug Screening Market, by Product Type
9.1. Introduction
9.2. Chromatography Systems
9.3. Confirmation Services
9.4. Consultation Services
9.5. Enzyme-Linked Immunosorbent Assay Kits
9.6. Lateral Flow Immunoassay Kits
9.7. Mass Spectrometers
9.8. PCR Instruments
9.9. Screening Services
10. Toxicology Drug Screening Market, by Sample Type
10.1. Introduction
10.2. Blood
10.2.1. Plasma
10.2.2. Whole Blood
10.3. Hair
10.4. Oral Fluid
10.5. Saliva
10.6. Urine
11. Toxicology Drug Screening Market, by Drug Class
11.1. Introduction
11.2. Amphetamines
11.3. Benzodiazepines
11.4. Cannabis
11.5. Cocaine
11.6. Opiates
12. Toxicology Drug Screening Market, by Application
12.1. Introduction
12.2. Clinical Diagnostics
12.3. Forensic Testing
12.4. Pain Management
12.5. Sports Anti-Doping
12.6. Workplace Testing
13. Toxicology Drug Screening Market, by End User
13.1. Introduction
13.2. Government And Military Laboratories
13.3. Home Care Testing
13.4. Hospitals And Clinics
13.5. Independent Laboratories
13.6. Research Institutes
14. Americas Toxicology Drug Screening Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Toxicology Drug Screening Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Toxicology Drug Screening Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Abbott Laboratories
17.3.3. F. Hoffmann-La Roche Ltd.
17.3.4. Siemens Healthineers AG
17.3.5. Agilent Technologies, Inc.
17.3.6. Shimadzu Corporation
17.3.7. PerkinElmer, Inc.
17.3.8. Waters Corporation
17.3.9. Bio-Rad Laboratories, Inc.
17.3.10. Randox Laboratories Ltd
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. TOXICOLOGY DRUG SCREENING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. TOXICOLOGY DRUG SCREENING MARKET: RESEARCHAI
FIGURE 28. TOXICOLOGY DRUG SCREENING MARKET: RESEARCHSTATISTICS
FIGURE 29. TOXICOLOGY DRUG SCREENING MARKET: RESEARCHCONTACTS
FIGURE 30. TOXICOLOGY DRUG SCREENING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. TOXICOLOGY DRUG SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PCR-BASED TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PCR-BASED TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY RAPID TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY RAPID TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CONFIRMATION SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CONFIRMATION SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CONSULTATION SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CONSULTATION SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ORAL FLUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ORAL FLUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CANNABIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CANNABIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COCAINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COCAINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY OPIATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY OPIATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SPORTS ANTI-DOPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SPORTS ANTI-DOPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY WORKPLACE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY WORKPLACE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GOVERNMENT AND MILITARY LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GOVERNMENT AND MILITARY LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HOME CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HOME CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 143. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 146. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 147. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 148. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 149. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 154. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 155. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 156. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 157. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 166. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 167. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 172. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 173. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 254. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 255. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 256. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 257. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 258. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 259. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 262. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 263. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 264. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 265. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 266. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 267. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 274. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 275. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 276. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 277. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 280. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 281. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 282. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 283. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 284. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 285. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 308. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 309. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 310. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 311. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 312. ITALY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Toxicology Drug Screening market report include:
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • Agilent Technologies, Inc.
  • Shimadzu Corporation
  • PerkinElmer, Inc.
  • Waters Corporation
  • Bio-Rad Laboratories, Inc.
  • Randox Laboratories Ltd

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 34.82 Billion
Forecasted Market Value ( USD ) by 2030 $ 65.31 Billion
Compound Annual Growth Rate13.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Neonatal Toxicology - Global Strategic Business Report - Product Image

Neonatal Toxicology - Global Strategic Business Report

  • Report
  • 475 Pages
  • Global
From
Toxicology Drug Screening Global Market Report 2025 - Product Image

Toxicology Drug Screening Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
In-Vitro Toxicology Testing Market by Service Type (Biochemical Assays, Cell Culture Assays, Computational Models), Technology (High Throughput Screening, Microfluidics, Organ On Chip), Application, End User - Global Forecast 2025-2030 - Product Image

In-Vitro Toxicology Testing Market by Service Type (Biochemical Assays, Cell Culture Assays, Computational Models), Technology (High Throughput Screening, Microfluidics, Organ On Chip), Application, End User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Toxicology Drug Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Toxicology Drug Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
ADME Toxicology Testing Market Report 2025 - Product Image

ADME Toxicology Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Market

The Toxicology Test market within the context of Diagnostics is a specialized field of testing that focuses on the detection of toxic substances in the body. It is used to identify the presence of drugs, alcohol, and other hazardous substances in the body. Toxicology tests are used to detect the presence of drugs in the body, to monitor drug levels in the body, and to assess the effects of drugs on the body. Toxicology tests are also used to detect the presence of hazardous substances in the environment, such as heavy metals, pesticides, and other pollutants. The Toxicology Test market is a rapidly growing field, with new technologies and methods being developed to improve accuracy and efficiency. Toxicology tests are used in a variety of settings, including clinical laboratories, research laboratories, and public health laboratories. Some companies in the Toxicology Test market include Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories, and Quest Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.